EPO and anemia (phenotype): Mouse models with targeted deletions of the genes encoding Epo or the Epo receptor (EpoR) are non-viable due to lethal anemia during embryonic development [121], whereas transgenic Epo overexpression causes massive erythrocytosis [84].